Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Schaper

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Progress in Clinical and Biological Research|January 1, 1989
QSAR analysis of chiral compounds including racematesK J Schaper
SAR and QSAR in Environmental Research|January 1, 1993
Application of neural networks in the QSAR analysis of percent effect biological data: comparison with adaptive least squares and nonlinear regression analysisM Wiese, K J Schaper
Immunitat Und Infektion|April 1, 1992
[A new, highly synergistic drug combination for the treatment of infections with multiresistant mycobacteria, especially the mycobacterium avium complex]J K Seydel, K J Schaper
Infection|March 7, 2006
Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogensK-J Schaper, S Schubert, A Dalhoff
The Journal of Pharmacy and Pharmacology|March 1, 1997
Estimation of the chemosensitizing activity of modulators of multi-drug resistance via combined simultaneous analysis of sigmoidal dose-response curvesG Ecker, P Chiba, K J Schaper
Archiv Der Pharmazie|May 6, 1999
Substituted xanthones as antimycobacterial agents. Part 3: QSAR investigationsK J Schaper, M Pickert, A W Frahm
Archiv Der Pharmazie|August 6, 1998
Substituted xanthones as antimycobacterial agents, Part 2: Antimycobacterial activityM Pickert, K J Schaper, A W Frahm
Immunobiology|October 1, 1994
Experimental drugs and combination therapyJ K Seydel, K J Schaper, S Rüsch-Gerdes
Arzneimittel-Forschung|June 1, 1997
Synthesis and antimycobacterial activity of nitroxanthones. 2nd communication: antimycobacterial activityW G Ibrom, K J Schaper, A W Frahm
Chemotherapy|January 1, 1992
Development of effective drug combinations for the inhibition of multiply resistant mycobacteria, especially of the Mycobacterium avium complexJ K Seydel, K J Schaper, S Rüsch-Gerdes
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Progress in Clinical and Biological Research|January 1, 1989
QSAR analysis of chiral compounds including racematesK J Schaper
SAR and QSAR in Environmental Research|January 1, 1993
Application of neural networks in the QSAR analysis of percent effect biological data: comparison with adaptive least squares and nonlinear regression analysisM Wiese, K J Schaper
Immunitat Und Infektion|April 1, 1992
[A new, highly synergistic drug combination for the treatment of infections with multiresistant mycobacteria, especially the mycobacterium avium complex]J K Seydel, K J Schaper
Infection|March 7, 2006
Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogensK-J Schaper, S Schubert, A Dalhoff
The Journal of Pharmacy and Pharmacology|March 1, 1997
Estimation of the chemosensitizing activity of modulators of multi-drug resistance via combined simultaneous analysis of sigmoidal dose-response curvesG Ecker, P Chiba, K J Schaper
Archiv Der Pharmazie|May 6, 1999
Substituted xanthones as antimycobacterial agents. Part 3: QSAR investigationsK J Schaper, M Pickert, A W Frahm
Archiv Der Pharmazie|August 6, 1998
Substituted xanthones as antimycobacterial agents, Part 2: Antimycobacterial activityM Pickert, K J Schaper, A W Frahm
Immunobiology|October 1, 1994
Experimental drugs and combination therapyJ K Seydel, K J Schaper, S Rüsch-Gerdes
Arzneimittel-Forschung|June 1, 1997
Synthesis and antimycobacterial activity of nitroxanthones. 2nd communication: antimycobacterial activityW G Ibrom, K J Schaper, A W Frahm
Chemotherapy|January 1, 1992
Development of effective drug combinations for the inhibition of multiply resistant mycobacteria, especially of the Mycobacterium avium complexJ K Seydel, K J Schaper, S Rüsch-Gerdes
Pageof 3